Research Article

Health Related Quality of Life in Individuals Transferred from a Needle Exchange Program and Starting Opioid Agonist Treatment

Table 1

Mean EQ-5D index scores and EQ-5D VAS scores in relation to particular reported baseline characteristics for 71 individuals starting OAT.

EQ-5D pEQ-5D VAS p
n (%)mean (s.d)mean (s.d)

Male53 (74.6)0.73 (0.17)0.92648.9 (24.9)0.469
Female18 (25.4)0.74 (0.13)42.6 (28.1)
Previous suicide attempts
 YES22 (31.0)0.69 (0.18)0.19336.5 (25.9)0.022
 NO49 (69.0)0.76 (0.15)51.8 (24.5)
Prescribed psychiatric medication
 YES18 (25.4)0.66 (0.16)0.02438.1 (22.5)0.078
 NO53 (74.6)0.76 (0.15)50.4 (26.2)
Using benzodiazepines last 30 days
 YES52 (73.2)0.72 (0.16)0.05544.2 (26.5)0.086
 NO19 (26.8)0.80 (0.12)56.2 (21.5)
Responders other illicit drugs
 YES9 (13.2)0.89 (0.10)0.00463.9 (21.7)0.038
 NO59 (86.8)0.72 (0.16)45.6 (25.1)
Responders opioids
 YES21 (30.9)0.80 (0.14)0.12955.8 (25.9)0.118
 NO47 (69.1)0.72 (0.16)44.6 (24.7)
Previous overdoses
 YES51 (71.8)0.74 (0.16)0.94044.4 (24.8)0.182
 NO20 (28.2)0.74 (0.15)54.7 (27.2)